Medicamen Organics IPO Date, Review, Price, Allotment Details

Medicamen Organics Limited is engaged in the development, manufacturing and distribution of a wide range of pharmaceutical dosages including generic dosages in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions and government dry powders (including both state and central government agencies). governments) and private institutions as contract manufacturer / third party manufacturer. They market their product to private pharmaceutical companies in both domestic and international markets through third party distributors or on a loan license basis. Furthermore, their company also strategically focuses on establishing a direct presence in the international market. For example, in fiscal year 2023, they exported their product directly to Burundi. They have a track record of operating a B2B model that includes the contract manufacturing model. Their products are marketed throughout India, as well as in African, CIS and Southeast Asian countries such as Congo, Benin, Cameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya . party distributor.

They have 2 WHO GMP approved manufacturing facilities located at 60 and 61, Sector 6A, IIE SIDCUL, Ranipur, Haridwar 249403, Uttarakhand, spread over 21,536 square meters. Their manufacturing facilities are capable of producing pharmaceutical formulations and products and have a fully equipped quality control department with experienced and qualified staff to facilitate a smooth production process. They have their own testing laboratory and the necessary infrastructure to test their raw materials and end products for quality standards. They are an ISO 9001:2015 certified company. their core strength lies in product development and documentation, which gives them an inherent strength in the market as they are regularly involved in research and development and new product launches. This gives them an ever-evolving product list and better prices in the market. Their product portfolio consists of 84 products and consists of a wide range of drugs such as antibacterial, antidiarrheal, antifungal, antimalarial, antidiabetic, proton pump inhibitor, antihistamine, antihypertensive, antilipidemic drug, anti Parasitic, multivitamin, multimineral and nonsteroidal anti-inflammatory drugs (NSAIDS).

Their company is consistent in providing quality products all year round. Their products meet the required safety standards. It is a quality-conscious company. They continually strive to expand their product range and are always looking for additional products that can complement their product range.

Objects of the issue:

• Financing the proposed costs for product registration in international markets
• Factory update and production capacity increase
• Financing our company’s working capital needs
• General business purposes

Medicamen Organics IPO Review

Medicamen Organics IPO Date and Price Band Details

Medicamen Organics IPO market lot

The minimum market lot of Medicamen Organics IPO is 4000 shares with an application amount of ₹136,000.

Medicamen Organics IPO dates

Medicamen Organics’ IPO date is June 21 and the IPO closing date is June 25. The IPO allotment date is June 26 and the IPO could be listed on June 28.

You can check the IPO subscription status and IPO allotment status on their respective pages.

Medicamen Organics IPO Form

How to apply Medicamen Organics IPO? You can apply for Medicamen Organics IPO through ASBA, available in your bank account. Simply go to the online bank login and apply via your bank account by selecting the Medicamen Organics IPO from the Invest section. The other option can be applied for IPO from Medicamen Organics by downloading IPO forms from the BSE website. View the Medicamen Organics forms – click on Download, complete and submit BSE IPO forms to your bank or broker.

Medicamen Organics Company Financial Report

Medicamen Organics IPO Valuation – FY 2023

View the details of Medicamen Organics’ IPO valuations, such as earnings per share (EPS), price-to-earnings ratio, return on net worth (RoNW) and net asset value (NAV).

Age group

• Brooks Laboratories Ltd
• Cian Healthcare Ltd
• Zenotech Laboratories Ltd

Medicamen Organics IPO Registrar

Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: (email protected)
Website: https://kosmic.kfintech.com/ipostatus/

Medicamen Organics IPO Allocation Status

Check the IPO allocation status of Medicamen Organics at the Kfintech website URL. click here

Medicamen Organics IPO Lead Managers aka Merchant Bankers

• GYR Capital Advisors Private Limited

Company Address

Medicamen Organics Limited
10 Community Center,
No. 2 Ashok Vihar Phase II,
New Delhi, Delhi, 110052
Telephone: +91-9818222845
E-mail: (email protected)
Website: http://www.medicamenorganics.com/

Medicamen Organics IPO Frequently Asked Questions

Note: Medicamen Organics IPO details have been officially announced. The IPO gray market premium (Medicamen Organics IPO Premium) is updated on the relevant page. You can check our IPO gray market page for daily updates.